Bronchiectasis Leukopak
Powered by BiozAbout:Bronchiectasis Leukopak is sourced from consented donors with documented bronchiectasis. These samples support immune-cell research, with donor information on condition, demographics, medications and comorbidities.
About Bronchiectasis Leukopak
Bronchiectasis Leukopak is sourced from consented donors with documented bronchiectasis. These samples support immune-cell research, with donor information on condition, demographics, medications and comorbidities.
Applications
- Bronchiectasis research
- Immune-cell phenotyping
- Downstream immune-cell isolation studies
- Cellular functional assays
- Translational immunology research
Product Features
- Human leukopak material
- Donor condition: Bronchiectasis
- Consented donor collection
- Research Use Only (RUO)
De-identified Donor Data
- Donor condition/diagnosis and documented clinical phenotype
- Age, gender and race/ethnicity
- Medications and comorbidities
- HLA typing and CMV status
- HIV, HBV, HCV and syphilis testing
- ABO/Rh blood type and country of collection
- Tobacco, alcohol, caffeine and recreational drug use
Processing specifications
- Anticoagulant
- Confirmed per lot on request
- Formats
- Cryopreserved, FreshBag sizesFull BagHalf Bag
- Processing window
- Processed within 24 hours of collection unless otherwise stated
- Cryopreservation
- Plasma-reduced; serum-free freezing medium with 10% DMSO; controlled-rate freezer
- Storage
- Vapor-phase liquid nitrogen
- Count and viability
- Total nucleated cell count and viability by AO/PI on a dual-fluorescence counter
From Sanguine's processing protocols. View protocols
Donor-level data is listed per lot when lots are in stock.
Need a field that isn't listed, such as disease stage or time since diagnosis?
Protocols & Documentation
-
Download
Leukopak Cryopreservation
Standard operating procedure for cryopreserving leukopak units with controlled freezing and post-thaw viability targets.
-
Download
Leukopak Thawing
Validated thawing workflow for cryopreserved leukopaks to maximize recovery while maintaining sterility and chain of custody.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Leukopak
Where can I find your complete catalog?
You can find our full product catalog here.
How long can samples be stored?
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
What customization options are available?
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
Do you offer prospective collections?
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
What is the turnaround time for custom collections?
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
Do you have samples in stock?
YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
What does unique donor mean?
Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
Are samples collected under IRB-approved protocols?
YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Frequently Asked Questions
Ask a Question
Pair with a Healthy Control
Match your Bronchiectasis Leukopak with normal donor samples for comparison
Healthy Donor Leukopaks
7 In Stock View InventoryNeed a custom Leukopak cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.